TCR T-cell Therapies: What if Magic Bullets Simply Aren’t Good Enough? (White Paper)

White Paper

November 19, 2021

Download pdf

TCR T-cell Therapies: What if Magic Bullets Simply Aren’t Good Enough?|

Joel S. Sandler, PhD, Principal, Cancer Cell Therapy Lead
Cello Health BioConsulting

On the heels of a recent post in which I discussed evolving dynamics and strategic implications underscoring different types of allogeneic cell therapies in oncology, I find it fitting to address another substantive consideration in the field, that of targeting moieties. Specifically, what can we say about the likely roles to be played by CAR- vs. TCR-modified cell therapies?…..More by clicking the Download pdf green button above.